Amy Mcbride Wendell - Net Worth and Insider Trading
Amy Mcbride Wendell Net Worth
The estimated net worth of Amy Mcbride Wendell is at least $2 Million dollars as of 2024-11-08. Amy Mcbride Wendell is the Director of Axogen Inc and owns about 80,342 shares of Axogen Inc (AXGN) stock worth over $1 Million. Amy Mcbride Wendell is the Director of Hologic Inc and owns about 10,297 shares of Hologic Inc (HOLX) stock worth over $816,449. Amy Mcbride Wendell is also the Director of Ekso Bionics Holdings Inc and owns about 1,084 shares of Ekso Bionics Holdings Inc (EKSO) stock worth over $965. Details can be seen in Amy Mcbride Wendell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Amy Mcbride Wendell has not made any transactions after 2023-09-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Amy Mcbride Wendell
Amy Mcbride Wendell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Amy Mcbride Wendell owns 4 companies in total, including Axogen Inc (AXGN) , Baxter International Inc (BAX) , and Hologic Inc (HOLX) among others .
Click here to see the complete history of Amy Mcbride Wendell’s form 4 insider trades.
Insider Ownership Summary of Amy Mcbride Wendell
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AXGN | Axogen Inc | 2023-09-06 | director |
BAX | Baxter International Inc | 2022-05-03 | director |
HOLX | Hologic Inc | 2018-03-14 | director |
2017-09-14 | director |
Amy Mcbride Wendell Latest Holdings Summary
Amy Mcbride Wendell currently owns a total of 3 stocks. Among these stocks, Amy Mcbride Wendell owns 80,342 shares of Axogen Inc (AXGN) as of September 6, 2023, with a value of $1 Million and a weighting of 56.6%. Amy Mcbride Wendell owns 10,297 shares of Hologic Inc (HOLX) as of March 14, 2018, with a value of $816,449 and a weighting of 43.35%. Amy Mcbride Wendell also owns 1,084 shares of Ekso Bionics Holdings Inc (EKSO) as of September 14, 2017, with a value of $965 and a weighting of 0.05%.
Latest Holdings of Amy Mcbride Wendell
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AXGN | Axogen Inc | 2023-09-06 | 80,342 | 13.27 | 1,066,138 |
HOLX | Hologic Inc | 2018-03-14 | 10,297 | 79.29 | 816,449 |
EKSO | Ekso Bionics Holdings Inc | 2017-09-14 | 1,084 | 0.89 | 965 |
Holding Weightings of Amy Mcbride Wendell
Amy Mcbride Wendell Form 4 Trading Tracker
According to the SEC Form 4 filings, Amy Mcbride Wendell has made a total of 1 transactions in Axogen Inc (AXGN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Axogen Inc is the acquisition of 10,000 shares on September 6, 2023, which cost Amy Mcbride Wendell around $62,200.
According to the SEC Form 4 filings, Amy Mcbride Wendell has made a total of 0 transactions in Hologic Inc (HOLX) over the past 5 years. The most-recent trade in Hologic Inc is the acquisition of 5,200 shares on March 14, 2018, which cost Amy Mcbride Wendell around $199,836.
According to the SEC Form 4 filings, Amy Mcbride Wendell has made a total of 0 transactions in Ekso Bionics Holdings Inc (EKSO) over the past 5 years. The most-recent trade in Ekso Bionics Holdings Inc is the acquisition of 1,084 shares on September 14, 2017, which cost Amy Mcbride Wendell around $20,005.
Insider Trading History of Amy Mcbride Wendell
- 1
Amy Mcbride Wendell Trading Performance
GuruFocus tracks the stock performance after each of Amy Mcbride Wendell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Amy Mcbride Wendell is 13.55%. GuruFocus also compares Amy Mcbride Wendell's trading performance to market benchmark return within the same time period. The performance of stocks bought by Amy Mcbride Wendell within 3 months outperforms 3 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Amy Mcbride Wendell's insider trading performs compared to the benchmark.
Performance of Amy Mcbride Wendell
Amy Mcbride Wendell Ownership Network
Ownership Network List of Amy Mcbride Wendell
Ownership Network Relation of Amy Mcbride Wendell
Amy Mcbride Wendell Owned Company Details
What does Axogen Inc do?
Who are the key executives at Axogen Inc?
Amy Mcbride Wendell is the director of Axogen Inc. Other key executives at Axogen Inc include Chief R&D Officer Angelo Scopelianos , director & CEO Karen L. Zaderej , and VP & Clinical&Translational Sc Erick Wayne Devinney .
Axogen Inc (AXGN) Insider Trades Summary
Over the past 18 months, Amy Mcbride Wendell made 1 insider transaction in Axogen Inc (AXGN) with a net purchase of 10,000. Other recent insider transactions involving Axogen Inc (AXGN) include a net sale of 74,448 shares made by Gregory Gene Freitag , a net sale of 42,343 shares made by Michael Patrick Donovan , and a net sale of 39,280 shares made by Karen L. Zaderej .
In summary, during the past 3 months, insiders sold 0 shares of Axogen Inc (AXGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 180,030 shares of Axogen Inc (AXGN) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 150,030 shares.
Axogen Inc (AXGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Axogen Inc Insider Transactions
Amy Mcbride Wendell Mailing Address
Above is the net worth, insider trading, and ownership report for Amy Mcbride Wendell. You might contact Amy Mcbride Wendell via mailing address: Covidien Ltd., 15 Hampshire Street, Mansfield Ma 02048.